Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?

被引：12
作者：
Bowen, DT [1 ]
Hellstrom-Lindberg, E
机构：
[1] Univ Dundee, Ninewells Hosp, Dundee DD1 9SY, Scotland
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Med, Div Haematol, S-14186 Huddinge, Sweden
来源：
LEUKEMIA RESEARCH | 2001年 / 25卷 / 01期
关键词：
D O I：
10.1016/S0145-2126(00)00100-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：19 / 21
页数：3
相关论文
共 12 条
  • [1] Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia
    Barosi, G
    Marchetti, M
    Liberato, NL
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (06) : 781 - 787
  • [2] Cast effectiveness, quality-adjusted life-years and supportive care - Recombinant human erythropoietin as a treatment of cancer-associated anaemia
    Cremieux, PY
    Finkelstein, SN
    Berndt, ER
    Crawford, J
    Slavin, MB
    [J]. PHARMACOECONOMICS, 1999, 16 (05) : 459 - 472
  • [3] Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
    Demetri, GD
    Kris, M
    Wade, J
    Degos, L
    Cella, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3412 - 3425
  • [4] International scoring system for evaluating prognosis in myelodysplastic syndromes
    Greenberg, P
    Cox, C
    LeBeau, MM
    Fenaux, P
    Morel, P
    Sanz, G
    Sanz, M
    Vallespi, T
    Hamblin, T
    Oscier, D
    Ohyashiki, K
    Toyama, K
    Aul, C
    Mufti, G
    Bennett, J
    [J]. BLOOD, 1997, 89 (06) : 2079 - 2088
  • [5] Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment
    Hast, R
    Wallvik, J
    Folin, A
    Bernell, P
    Stenke, L
    [J]. LEUKEMIA RESEARCH, 2001, 25 (01) : 13 - 18
  • [6] Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin:: Results from a randomized phase II study and long-term follow-up of 71 patients
    Hellström-Lindberg, E
    Ahlgren, T
    Beguin, Y
    Carlsson, M
    Carneskog, J
    Dahl, IM
    Dybedal, I
    Grimfors, G
    Kanter-Lewensohn, L
    Linder, O
    Luthman, M
    Löfvenberg, E
    Nilsson-Ehle, H
    Samuelsson, J
    Tangen, JM
    Winqvist, I
    Öberg, G
    Österborg, A
    Öst, Å
    [J]. BLOOD, 1998, 92 (01) : 68 - 75
  • [7] Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model
    HellstromLindberg, E
    Negrin, R
    Stein, R
    Krantz, S
    Lindberg, G
    Vardiman, J
    Ost, A
    Greenberg, P
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) : 344 - 351
  • [8] EFFICACY OF ERYTHROPOIETIN IN THE MYELODYSPLASTIC SYNDROMES - A METAANALYSIS OF 205 PATIENTS FROM 17 STUDIES
    HELLSTROMLINDBERG, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (01) : 67 - 71
  • [9] Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin
    Mantovani, L
    Lentini, C
    Hentschel, B
    Wickramanayake, PD
    Loeffler, M
    Diehl, V
    Tesch, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (02) : 367 - 375
  • [10] Perrini PR, 1998, BRIT J HAEMATOL, V103, P1070
12